Adenomatous Polyposis Coli: Clinical Trials

22 trials for Adenomatous Polyposis Coli, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

11 completed, 4 recruiting, 4 unknown, 1 not yet recruiting. 22 Phase 2, 3 Phase 1, 3 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 222Completed 11, Recruiting 4, Unknown 4, Not yet recruiting 1, Terminated 1, Withdrawn 1
Phase 13Recruiting 3
Phase 33Completed 2, Unknown 1

Follow Adenomatous Polyposis Coli: new trials by email Literature Review of Adenomatous Polyposis Coli trials Research Report on Adenomatous Polyposis Coli

Trials (filtered) newest first · largest first

All 22 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Safety Study for the Use of Rapamycin in Children With Familial Adenomatous Polyposis
Rapamycin - Familial Adenomatous Polyposis
Phase 2Not yet recruitingUniversity Hospital, Toulouse252026-09-012026-05-08
TPST-1495 in Patients With Familial Adenomatous Polyposis
Biopsy Procedure, Biospecimen Collection, EP2/EP4 Antagonist TPST-1495 - Colorectal Carcinoma, Familial Adenomatous Polyposis
Phase 2RecruitingNational Cancer Institute (NCI)382026-03-312026-11-18
Safety and Efficacy of Tegavivint in Patients With Metastatic Colorectal Carcinoma
Tegavivint - Metastatic Colorectal Carcinoma (mCRC), Colorectal Cancer (CRC)
Phase 1 / Phase 2RecruitingHonorHealth Research Institute1262026-02-172026-03-11
Evaluate REC-4881 in Participants With Familial Adenomatous Polyposis (FAP)
REC-4881, Placebo - Familial Adenomatous Polyposis
Phase 1 / Phase 2RecruitingRecursion Pharmaceuticals Inc.672023-07-102026-06-05
FOG-001 in Locally Advanced or Metastatic Solid Tumors
FOG-001, mFOLFOX-6, Nivolumab - Cancer, Colorectal Cancer
Phase 1 / Phase 2RecruitingParabilis Medicines, Inc.6192023-05-232026-10-07
Testing Obeticholic Acid for Familial Adenomatous Polyposis
Biopsy Procedure, Biospecimen Collection, Gastrointestinal Endoscopy - Attenuated Familial Adenomatous Polyposis, Colorectal Carcinoma
Phase 2TerminatedNational Cancer Institute (NCI)152023-01-192026-05-14
The CHAMP-study: The CHemopreventive Effect of Lithium in Familial AdenoMatous Polyposis
Lithium Carbonate - Familial Adenomatous Polyposis
Phase 2CompletedAcademisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)122022-06-022024-10-04
Trial of eRapa to Prevent Progression in Familial Adenomatous Polyposis Patients Under Active Surveillance
Encapsulated Rapamycin (eRapa) - Familial Adenomatous Polyposis
Phase 2CompletedRapamycin Holdings Inc.302021-01-182026-10-22
Niclosamide for Familial Adenomatous Polyposis
Niclosamide, placebo - Familial Adenomatous Polyposis
Phase 2UnknownYonsei University722020-02-142020-03-05
Erlotinib Hydrochloride in Reducing Duodenal Polyp Burden in Patients With Familial Adenomatous Polyposis at Risk of Developing Colon Cancer
Erlotinib, Erlotinib Hydrochloride - Attenuated Familial Adenomatous Polyposis, Familial Adenomatous Polyposis
Phase 2CompletedNational Cancer Institute (NCI)462017-10-272022-07-26
Sirolimus and Familial Adenomatous Polyposis (FAP)
Sirolimus - Adenomatous Polyposis Coli
Phase 2CompletedAcademisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)42017-10-032024-10-24
Turmeric Supplementation on Polyp Number and Size in Patients With Familial Adenomatous Polyposis.
Wholistic Turmeric capsules, Placebo - Familial Adenomatous Polyposis, FAP
Phase 2UnknownTel-Aviv Sourasky Medical Center402017-04-012017-02-23
The Chemopreventive Effect of Metformin in Patients With Familial Adenomatous Polyposis: Double Blinded Randomized Controlled Study
Metformin, Placebo - Familial Adenomatous Polyposis
Phase 2CompletedYonsei University342013-02-152021-09-20
Curcumin in Treating Patients With Familial Adenomatous Polyposis
Curcumin, Laboratory Biomarker Analysis, Placebo - Familial Adenomatous Polyposis
Phase 2CompletedNational Cancer Institute (NCI)442010-10-012017-09-29
A Clinical Trial of COX and EGFR Inhibition in Familial Polyposis Patients
Erlotinib, Sulindac, Placebo A - Adenomatous Polyposis Coli
Phase 2CompletedUniversity of Utah922010-04-012016-06-17
Prevention of Progression of Duodenal Adenomas in Patients With Familial Adenomatous Polyposis
Celecoxib, Ursodeoxycholic acid, Placebo - Familial Adenomatous Polyposis, Duodenal Neoplasms
Phase 2 / Phase 3CompletedRadboud University Medical Center372009-05-012013-05-16
Chemoprevention Trial in Familial Adenomatous Polyposis (FAP) Coli Using EPA
Eicosapentanoic Acid (EPA), Endoscopy, Biopsies taken - Familial Adenomatous Polyposis Coli, FAP
Phase 2 / Phase 3CompletedS.L.A. Pharma AG582006-11-012014-08-22
Influence of Sulindac and Probiotics on the Development of Pouch Adenomas in Patients With Familial Adenomatous Polyposis
Sulindac (drug), VSL#3 (probiotic), Inulin (probiotic) - Adenomatous Polyposis Coli
Phase 2UnknownRadboud University Medical Center302006-04-012007-08-10
Use of Curcumin in the Lower Gastrointestinal Tract in Familial Adenomatous Polyposis Patients
curcumin - Familial Adenomatous Polyposis
Phase 2WithdrawnJohns Hopkins University2005-11-012012-09-20
Ursodeoxycholic Acid in the Treatment of Duodenal Adenomas in Familial Adenomatous Polyposis (FAP) Patients
Ursodeoxycholic acid, Placebo - Adenomatous Polyposis Coli, Familial
Phase 2 / Phase 3UnknownAssistance Publique - Hôpitaux de Paris902004-10-012009-07-29

Showing 20 of 22. Sign in to see all of them.

Narrower conditions

Colorectal Neoplasms (6)  ·  Adenoma (2)  ·  Attenuated familial adenomatous polyposis (2)  ·  Duodenal Neoplasms (2)  ·  Polyps (2)  ·  Adenomatous Polyps (1)  ·  Carcinoma, Hepatocellular (1)  ·  Craniopharyngioma (1)  ·  Desmoid Tumors (1)  ·  Digestive System Diseases (1)  ·  Digestive System Neoplasms (1)  ·  Endometrial Neoplasms (1)  ·  Gastrointestinal Diseases (1)  ·  Gastrointestinal Neoplasms (1)

Broader conditions

Colonic Diseases (22)  ·  Congenital, Hereditary, and Neonatal Diseases and Abnormalities (22)  ·  Intestinal Polyposis (22)  ·  Neoplasms by Histologic Type (22)  ·  Neoplasms by Site (22)  ·  Neoplasms, Glandular and Epithelial (22)  ·  Adenomatous Polyps (21)  ·  Digestive System Diseases (21)  ·  Digestive System Neoplasms (21)  ·  Gastrointestinal Diseases (21)  ·  Gastrointestinal Neoplasms (21)  ·  Genetic Diseases, Inborn (21)  ·  Intestinal Diseases (21)  ·  Intestinal Neoplasms (21)  ·  Neoplasms (21)

Interventions

Celecoxib (3)  ·  Biopsy (2)  ·  Curcumin (2)  ·  Endoscopy, Gastrointestinal (2)  ·  Erlotinib Hydrochloride (2)  ·  Sirolimus (2)  ·  Specimen Handling (2)  ·  Sulindac (2)  ·  Ursodeoxycholic Acid (2)  ·  Bevacizumab (1)  ·  Eflornithine (1)  ·  Eicosapentaenoic Acid (1)  ·  Endoscopy (1)  ·  Endoscopy, Digestive System (1)  ·  Fluorouracil (1)

Sponsors

National Cancer Institute (NCI) (5)  ·  Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) (2)  ·  Radboud University Medical Center (2)  ·  Yonsei University (2)  ·  Assistance Publique - Hôpitaux de Paris (1)  ·  HonorHealth Research Institute (1)  ·  Johns Hopkins University (1)  ·  M.D. Anderson Cancer Center (1)  ·  Parabilis Medicines, Inc. (1)  ·  Rapamycin Holdings Inc. (1)  ·  Recursion Pharmaceuticals Inc. (1)  ·  S.L.A. Pharma AG (1)  ·  Tel-Aviv Sourasky Medical Center (1)  ·  University Hospital, Toulouse (1)  ·  University of Utah (1)

Countries

United States (11)  ·  Netherlands (4)  ·  Puerto Rico (3)  ·  France (2)  ·  South Korea (2)  ·  Australia (1)  ·  United Kingdom (1)

Top investigators

Niloy J Samadder (2)  ·  Benjamin Oshrine (1)  ·  Bjorn WH van Heumen, MD (1)  ·  Eduardo Vilar-Sanchez (1)  ·  Ellen Kampman, Ph D (1)  ·  Emmanuel Mas, Pr (1)  ·  Evelien Dekker, MD, PhD (1)  ·  Fokko M Nagengast, MD, Ph D (1)  ·  Fokko M Nagengast, PhD (1)  ·  Francis Giardiello (1)  ·  Francis M Giardiello, M.D. (1)  ·  Gary Shangold, MD (1)  ·  Imad Shureiqi, MD (1)  ·  Nicholas J West, MB BS FRCS (1)  ·  Niloy J Samadder, MD (1)

Results publications

PMID 37119510, PMID 20348368, PMID 21899713, PMID 23919274, PMID 24245549, PMID 25792707, PMID 27002448, PMID 29423501, PMID 29802852, PMID 30012100, PMID 33376109, PMID 33509804, PMID 35636921, PMID 35962368, PMID 39956770

NIH funding

P30CA016672 (2), N01CN00042 (1), P01CA073992 (1), P30CA006973 (1), P30CA014520 (1), P30CA015083 (1), R01CA106577 (1), R01CA134620 (1), UG1CA242596 (1), UG1CA242609 (1), UG1CA242635 (1)